112 related articles for article (PubMed ID: 9085557)
1. Varying effects of cyclodextrin derivatives on aggregation and thermal behavior of insulin in aqueous solution.
Tokihiro K; Irie T; Uekama K
Chem Pharm Bull (Tokyo); 1997 Mar; 45(3):525-31. PubMed ID: 9085557
[TBL] [Abstract][Full Text] [Related]
2. Stabilizing and solubilizing effects of sulfobutyl ether beta-cyclodextrin on prostaglandin E1 analogue.
Uekama K; Hieda Y; Hirayama F; Arima H; Sudoh M; Yagi A; Terashima H
Pharm Res; 2001 Nov; 18(11):1578-85. PubMed ID: 11758766
[TBL] [Abstract][Full Text] [Related]
3. Improvement of some pharmaceutical properties of DY-9760e by sulfobutyl ether beta-cyclodextrin.
Nagase Y; Hirata M; Wada K; Arima H; Hirayama F; Irie T; Kikuchi M; Uekama K
Int J Pharm; 2001 Oct; 229(1-2):163-72. PubMed ID: 11604269
[TBL] [Abstract][Full Text] [Related]
4. Protection afforded by maltosyl-beta-cyclodextrin against alpha-chymotrypsin-catalyzed hydrolysis of a luteinizing hormone-releasing hormone agonist, buserelin acetate.
Matsubara K; Ando Y; Irie T; Uekama K
Pharm Res; 1997 Oct; 14(10):1401-5. PubMed ID: 9358553
[TBL] [Abstract][Full Text] [Related]
5. Effects of cyclodextrins on chemically and thermally induced unfolding and aggregation of lysozyme and basic fibroblast growth factor.
Tavornvipas S; Hirayama F; Takeda S; Arima H; Uekama K
J Pharm Sci; 2006 Dec; 95(12):2722-9. PubMed ID: 16917853
[TBL] [Abstract][Full Text] [Related]
6. Comparative studies of the enhancing effects of cyclodextrins on the solubility and oral bioavailability of tacrolimus in rats.
Arima H; Yunomae K; Miyake K; Irie T; Hirayama F; Uekama K
J Pharm Sci; 2001 Jun; 90(6):690-701. PubMed ID: 11357172
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effect of sulfobutyl ether beta-cyclodextrin on DY-9760e-induced cellular damage: In vitro and in vivo studies.
Nagase Y; Arima H; Wada K; Sugawara T; Satoh H; Hirayama F; Uekama K
J Pharm Sci; 2003 Dec; 92(12):2466-74. PubMed ID: 14603492
[TBL] [Abstract][Full Text] [Related]
8. Differential effects of sulfate and sulfobutyl ether of beta-cyclodextrin on erythrocyte membranes in vitro.
Shiotani K; Uehata K; Irie T; Uekama K; Thompson DO; Stella VJ
Pharm Res; 1995 Jan; 12(1):78-84. PubMed ID: 7724491
[TBL] [Abstract][Full Text] [Related]
9. A moderate interaction of maltosyl-alpha-cyclodextrin with Caco-2 cells in comparison with the parent cyclodextrin.
Ono N; Arima H; Hirayama F; Uekama K
Biol Pharm Bull; 2001 Apr; 24(4):395-402. PubMed ID: 11305602
[TBL] [Abstract][Full Text] [Related]
10. Improvement of subcutaneous bioavailability of insulin by sulphobutyl ether beta-cyclodextrin in rats.
Tokihiro K; Arima H; Tajiri S; Irie T; Hirayama F; Uekama K
J Pharm Pharmacol; 2000 Aug; 52(8):911-7. PubMed ID: 11007061
[TBL] [Abstract][Full Text] [Related]
11. Release characteristics of endogenous constituents by exposure of small intestine to modified beta-cyclodextrins.
Tanino T; Ogiso T; Iwaki M; Yamaguchi T; Kakehi K
Biol Pharm Bull; 1999 Oct; 22(10):1099-105. PubMed ID: 10549863
[TBL] [Abstract][Full Text] [Related]
12. Experimental, molecular docking investigations and bioavailability study on the inclusion complexes of finasteride and cyclodextrins.
Mady FM; Farghaly Aly U
Drug Des Devel Ther; 2017; 11():1681-1692. PubMed ID: 28652706
[TBL] [Abstract][Full Text] [Related]
13. Solubility and mass and nuclear magnetic resonance spectroscopic studies on interaction of cyclosporin A with dimethyl-alpha- and -beta-cyclodextrins in aqueous solution.
Miyake K; Hirayama F; Uekama K
J Pharm Sci; 1999 Jan; 88(1):39-45. PubMed ID: 9874700
[TBL] [Abstract][Full Text] [Related]
14. Effect of sulfobutyl ether-β-cyclodextrin on bioavailability of insulin glargine and blood glucose level after subcutaneous injection to rats.
Uehata K; Anno T; Hayashida K; Motoyama K; Hirayama F; Ono N; Pipkin JD; Uekama K; Arima H
Int J Pharm; 2011 Oct; 419(1-2):71-6. PubMed ID: 21803140
[TBL] [Abstract][Full Text] [Related]
15. Protective effect of sulfobutyl ether beta-cyclodextrin on DY-9760e-induced hemolysis in vitro.
Nagase Y; Hirata M; Arima H; Tajiri S; Nishimoto Y; Hirayama F; Irie T; Uekama K
J Pharm Sci; 2002 Nov; 91(11):2382-9. PubMed ID: 12379923
[TBL] [Abstract][Full Text] [Related]
16. Inclusion complex formation of captopril with alpha- and beta-cyclodextrins in aqueous solution: NMR spectroscopic and molecular dynamic studies.
Ikeda Y; Motoune S; Matsuoka T; Arima H; Hirayama F; Uekama K
J Pharm Sci; 2002 Nov; 91(11):2390-8. PubMed ID: 12379924
[TBL] [Abstract][Full Text] [Related]
17. A study of the percutaneous absorption-enhancing effects of cyclodextrin derivatives in rats.
Vollmer U; Müller BW; Peeters J; Mesens J; Wilffert B; Peters T
J Pharm Pharmacol; 1994 Jan; 46(1):19-22. PubMed ID: 8201522
[TBL] [Abstract][Full Text] [Related]
18. Potential use of gamma-cyclodextrin polypseudorotaxane hydrogels as an injectable sustained release system for insulin.
Abu Hashim II; Higashi T; Anno T; Motoyama K; Abd-ElGawad AE; El-Shabouri MH; Borg TM; Arima H
Int J Pharm; 2010 Jun; 392(1-2):83-91. PubMed ID: 20298768
[TBL] [Abstract][Full Text] [Related]
19. Sildenafil/cyclodextrin complexation: stability constants, thermodynamics, and guest-host interactions probed by 1H NMR and molecular modeling studies.
Al Omari MM; Zughul MB; Davies JE; Badwan AA
J Pharm Biomed Anal; 2006 Jun; 41(3):857-65. PubMed ID: 16527440
[TBL] [Abstract][Full Text] [Related]
20. Cooperative molecular recognition of dyes by dyad and triad cyclodextrin-crown ether conjugates.
Liu Y; Yang YW; Li L; Chen Y
Org Biomol Chem; 2004 May; 2(10):1542-8. PubMed ID: 15136812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
